TY - JOUR
T1 - Platinum-refractory oral cancers could have a poorer therapeutic response to immunotherapy than their non-oral counterparts
AU - Devaraja, K.
PY - 2022/10/1
Y1 - 2022/10/1
UR - http://www.scopus.com/inward/record.url?scp=85151012604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85151012604&partnerID=8YFLogxK
U2 - 10.4103/crst.crst_307_22
DO - 10.4103/crst.crst_307_22
M3 - Letter
AN - SCOPUS:85151012604
SN - 2590-3233
VL - 5
SP - 779
EP - 780
JO - Cancer Research, Statistics, and Treatment
JF - Cancer Research, Statistics, and Treatment
IS - 4
ER -